Collegium Pharmaceutical Inc’s filing revealed that its EVP and Chief Medical Officer Smith Thomas B unloaded Company’s shares for reported $0.35 million on Sep 13 ’24. In the deal valued at $36.62 per share,9,593 shares were sold. As a result of this transaction, Smith Thomas B now holds 53,816 shares worth roughly $2.25 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Smith Thomas B bought 373 shares, generating $13,794 in total proceeds.
Before that, Smith Thomas B bought 9,220 shares. Collegium Pharmaceutical Inc shares valued at $337,516 were divested by the Officer at a price of $36.61 per share.
H.C. Wainwright upgraded its Collegium Pharmaceutical Inc [COLL] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early June from “a Hold” to “a Buy”. Piper Sandler also remained covering COLL and has decreased its forecast on May 10, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Needham revised its rating on May 10, 2024. It rated COLL as “a Hold” which previously was an “a Buy”.
Price Performance Review of COLL
On Friday, Collegium Pharmaceutical Inc [NASDAQ:COLL] saw its stock jump 4.94% to $41.86. Over the last five days, the stock has gained 9.41%. Collegium Pharmaceutical Inc shares have risen nearly 36.00% since the year began. Nevertheless, the stocks have risen 77.52% over the past one year. While a 52-week high of $40.95 was reached on 10/04/24, a 52-week low of $20.95 was recorded on 05/10/24. SMA at 50 days reached $37.17, while 200 days put it at $35.02.
Levels Of Support And Resistance For COLL Stock
The 24-hour chart illustrates a support level at 40.39, which if violated will result in even more drops to 38.92. On the upside, there is a resistance level at 42.78. A further resistance level may holdings at 43.70. The Relative Strength Index (RSI) on the 14-day chart is 70.17, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.49, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 7.06%. Stochastics %K at 80.97% indicates the stock is a selling.
How much short interest is there in Collegium Pharmaceutical Inc?
A steep rise in short interest was recorded in Collegium Pharmaceutical Inc stocks on 2024-09-13, growing by 0.24 million shares to a total of 6.35 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 6.11 million shares. There was a rise of 3.73%, which implies that there is a positive sentiment for the stock.
